CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Exalenz Bioscience Ltd. is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Exalenz Bioscience Ltd.
4 Ha maayan St.
Phone: +972 89737500p:+972 89737500 Modiin, 7177872  Israel Fax: +972 89737501f:+972 89737501
This is a Subsidiary, click here for the Parent Company
Business Summary
Exalenz Bioscience Ltd is an Israel-based company active in the medical sector. It develops and commercializes advanced systems that extract vital information for diagnostics from subtle changes in the patient's exhaled breath. Its core technology enables medical specialists to identify and manage specific digestive and liver conditions. The Company's product, the BreathID System, is used for assessment and monitoring of functional diseases of the liver and gastrointestinal tract. The BreathID System is mobile and can be operated in any clinical setting. The Company conducts ongoing research in collaboration with clinical and industrial partners in the United States, Europe, Asia, and Israel.
(Source: Company's Website)

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
-Yes-Yes---

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
6/30/202012/31/2019Yes----

Industries
SIC Code Description
3845 Electromedical and electrotherapeutic apparatus

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Chairman of the Board UriGeiger 54 1/23/2009 4/11/2006
Chief Executive Officer RaphaelWerner 56 7/1/2015 10/1/2010
Finance Director DavidStolick 52 5/1/2018 4/7/2010
12 additional Officers and Directors records available in full report.

General Information
Number of Employees: 47 (As of 12/31/2014)
Outstanding Shares: 26,917,095 (As of 6/30/2020)
Stock Exchange: TLV
Fax Number: +972 89737501


Copyright © 2024 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Monday, January 1, 2024